| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |